STOCK TITAN

Morgan Stanley’s XOMA Royalty Corp (XOMA) ownership rises to 13.7%

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Morgan Stanley and Morgan Stanley Investment Management Inc. filed an amended Schedule 13G reporting significant ownership in XOMA Royalty Corp common stock. They report beneficial ownership of 1,702,545 shares, representing 13.7% of the class, with voting and dispositive power shared through affiliated entities.

The filers state the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of XOMA Royalty Corp.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Morgan Stanley
Signature:Christopher O'Hara
Name/Title:Authorized Signatory, Morgan Stanley
Date:02/12/2026
Morgan Stanley Investment Management Inc.
Signature:Deidre A. Downes
Name/Title:Authorized Signatory, Morgan Stanley Investment Management Inc.
Date:02/12/2026
Exhibit Information

EXHIBIT NO. EXHIBITS ------------------ ------------------------------------ 99.1 Joint Filing Agreement 99.2 Item 7 Information * Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001).

FAQ

What stake in XOMA (XOMA) does Morgan Stanley report in this Schedule 13G/A?

Morgan Stanley and Morgan Stanley Investment Management Inc. report beneficial ownership of 1,702,545 shares of XOMA Royalty Corp common stock, representing 13.7% of the outstanding class, indicating a sizable institutional position in the company’s equity.

Which Morgan Stanley entities are listed as reporting persons for XOMA (XOMA)?

The filing lists Morgan Stanley and Morgan Stanley Investment Management Inc. as reporting persons. Both are organized in Delaware and report beneficial ownership and shared voting and dispositive power over XOMA Royalty Corp common stock through their relevant operating units.

Does Morgan Stanley seek to influence control of XOMA Royalty Corp (XOMA)?

The filing states the XOMA Royalty Corp securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control or participating in any transaction aimed at altering control of the issuer.

How many XOMA (XOMA) shares does Morgan Stanley Investment Management Inc. report?

Morgan Stanley Investment Management Inc. reports beneficial ownership of 1,700,925 shares of XOMA Royalty Corp common stock, with shared voting and shared dispositive power over those shares, contributing to the overall 13.7% ownership disclosed in the filing.

What type of reporting persons are Morgan Stanley and its affiliate in this XOMA filing?

Morgan Stanley is classified as a parent holding company or control person (HC), and Morgan Stanley Investment Management Inc. is classified as an investment adviser (IA). These classifications reflect their regulatory status under the Schedule 13G beneficial ownership reporting framework.

What is the event date associated with Morgan Stanley’s XOMA (XOMA) Schedule 13G/A?

The Schedule 13G/A cites December 31, 2025 as the date of the event requiring the filing. This date anchors when the reported beneficial ownership levels in XOMA Royalty Corp common stock were relevant for disclosure purposes under beneficial ownership rules.
XOMA Royalty Corporation

NASDAQ:XOMA

XOMA Rankings

XOMA Latest News

XOMA Latest SEC Filings

XOMA Stock Data

291.87M
12.16M
0.94%
68.02%
2.19%
Biotechnology
Pharmaceutical Preparations
Link
United States
EMERYVILLE